Popular
This Week This Month
Storyboards
Sign In
to Vote &
Create Storyboards.
 

New promise for patients with primary progressive multiple sclerosis

Science Daily - 26 Feb 2016 22:04
Abstract describes efficacy of ocrelizumab in patients with PPMS with and without T1 gadolinium-enhancing lesions at baseline in a Phase III, placebo-controlled trial.
Full Article at Science Daily

More Science News
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}     {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}

    • Create Storyboard